Taking people in EgyptPhase 4
Testing GABA for attention problems and seizures in children with epilepsy
Tests the drug GABA in children aged 4 to 18 with epilepsy.
Key facts
- Who runs it
- Sherief Abd-Elsalam
- Where
- Tanta, EgyptSee the site
- Trial code
- Registry title
- Effect of GABA on ADHD and Seizures in Children With Epilepsy.
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 30 people, planned
- Started
- 1 Jul 2018
- Expected to end
- 1 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- GABA
- Record updated
- 30 October 2019
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers who have both epilepsy and ADHD.
- Age
- 4 Years to 18 Years
- Sex
- All sexes can join.
- Disease stage
- Epilepsy together with ADHD.
Main reasons for not taking part
- Epilepsy without ADHD
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Epilepsy
- ADHD
Who cannot take part
- Epilepsy without ADHD
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 4 and 18 years old?
Where in Egypt
- Sherief Abd-ElsalamTanta, EgyptContact: Abeer Salamah, MscTaking people
About the trial
What the trial wants to find out
Effect of GABA on ADHD and seizures in Children with epilepsy.
The 2 groups in the trial
- Before treatmentNo study treatment, for comparison
no intervention
- After treatmentExisting treatment, for comparison
GABA
Treatment: GABA
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Gamma Aminobutyric Acid on ADHD and Seizures in Children With Epilepsy.
- Plain-language title
- Testing GABA for attention problems and seizures in children with epilepsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04144439, who can take part
- Record updated
- 30 October 2019